| Literature DB >> 29147054 |
Hannah H Leslie1, Donna Spiegelman2, Xin Zhou2, Margaret E Kruk1.
Abstract
OBJECTIVE: To evaluate the service readiness of health facilities in Bangladesh, Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Uganda and the United Republic of Tanzania.Entities:
Mesh:
Year: 2017 PMID: 29147054 PMCID: PMC5677617 DOI: 10.2471/BLT.17.191916
Source DB: PubMed Journal: Bull World Health Organ ISSN: 0042-9686 Impact factor: 9.408
Sample size for each item used in the evaluation of service readiness indexes, 10 countries, 2007–2015
| Domains and items | No. of facilities | |||
|---|---|---|---|---|
| With valid data | With non-systematically missing data | With systematically missing data | ||
| Item not investigated in some facilities | Item not investigated in whole national assessment | |||
| Electricity – i.e. uninterrupted power source or functional generator with fuel | 8443 | 0 | 0 | 0 |
| Safe water – i.e. improved source within 500 m of the facility | 8424 | 19 | 0 | 0 |
| Exam room with auditory and visual privacy | 8433 | 10 | 0 | 0 |
| Client sanitation facilities | 7972 | 60 | 0 | 411c |
| Communication equipment – i.e. functional phone or shortwave radio | 8436 | 7 | 0 | 0 |
| Computer with email and internet | 8443 | 0 | 0 | 0 |
| Emergency transportation | 8441 | 2 | 0 | 0 |
| Adult scale | 7981 | 12 | 450 | 0 |
| Paediatric scale | 8261 | 6 | 176 | 0 |
| Thermometer | 8263 | 4 | 176 | 0 |
| Stethoscope | 8214 | 1 | 228 | 0 |
| Blood pressure apparatus | 8214 | 1 | 228 | 0 |
| Light source | 8226 | 2 | 215 | 0 |
| Safe final disposal of sharps | 8218 | 161 | 64 | 0 |
| Safe final disposal of infectious waste | 8287 | 107 | 49 | 0 |
| Sharps box/container in exam room | 8443 | 0 | 0 | 0 |
| Waste bin with lid and liner in exam room | 8443 | 0 | 0 | 0 |
| Surface disinfectant | 8443 | 0 | 0 | 0 |
| Single-use standard disposable or auto-disposable syringes | 8443 | 0 | 0 | 0 |
| Soap and running water or alcohol-based hand sanitizer | 8443 | 0 | 0 | 0 |
| Latex gloves | 8443 | 0 | 0 | 0 |
| Guidelines for standard precautions against infection | 8443 | 0 | 0 | 0 |
| Haemoglobin test | 5470 | 3 | 2970 | 0 |
| Blood glucose test | 5470 | 3 | 2970 | 0 |
| Malaria diagnostic capacity | 5043 | 3 | 1849 | 1548d |
| Urine dipstick for protein | 5470 | 3 | 2970 | 0 |
| Urine dipstick for glucose | 5470 | 3 | 2970 | 0 |
| HIV diagnostic capacity | 5043 | 3 | 1849 | 1548d |
| Syphilis rapid diagnostic test | 5472 | 1 | 2970 | 0 |
| Urine pregnancy test | 5470 | 3 | 2970 | 0 |
| Amitriptyline tablet | 6114 | 0 | 194 | 2135e |
| Amlodipine tablet or alternative calcium channel blocker | 6114 | 0 | 194 | 2135e |
| Amoxicillin syrup/suspension or dispersible tablet | 8106 | 2 | 335 | 0 |
| Amoxicillin tablet | 8106 | 2 | 335 | 0 |
| Ampicillin powder for injection | 8108 | 0 | 335 | 0 |
| Beclometasone inhaler | 6114 | 0 | 194 | 2135e |
| Ceftriaxone injection | 8104 | 4 | 335 | 0 |
| Enalapril tablet or alternative ACE inhibitor | 6114 | 0 | 194 | 2135e |
| Fluoxetine tablet | 0 | 0 | 0 | 7480f |
| Gentamicin injection | 8104 | 4 | 335 | 0 |
| Glibenclamide tablet | 6114 | 0 | 194 | 2135e |
| Ibuprofen tablet | 5378 | 4 | 241 | 2820g |
| Insulin injection | 6114 | 0 | 194 | 2135e |
| Metformin tablet | 6114 | 0 | 194 | 2135e |
| Omeprazole tablet or alternative – e.g. pantoprazole or rabeprazole | 6114 | 0 | 194 | 2135e |
| Oral rehydration solution | 8106 | 2 | 335 | 0 |
| Paracetamol tablet | 8105 | 3 | 335 | 0 |
| Salbutamol inhaler | 6114 | 0 | 194 | 2135e |
| Simvastatin tablet or other statin – e.g. atorvastatin, pravastatin or fluvastatin | 6114 | 0 | 194 | 2135e |
| Zinc sulfate tablet or syrup | 6114 | 0 | 194 | 2135e |
ACE: angiotensin converting enzyme; HIV: human immunodeficiency virus.
a Item was included but no valid response recorded for a given facility.
b Item was included in national service provision assessment but only investigated if the facility offered the relevant clinical service.
c Missing from data for Namibia.
d Missing from data for Bangladesh.
e Missing from data for Kenya, Namibia, Rwanda and Uganda.
f Not asked in any country. Since fluoxetine had not been assessed in any of the service provision assessments used as our data sources, we excluded it from our analyses.
g Missing from data for Haiti, Senegal and United Republic of Tanzania.
Characteristics of 10 countries in study sample, 2007–2015
| Country | Year of SPA | No. of facilities surveyed | GDP per capita (US$) | THE per capita (US$) | OOPE (% of THE) | ERFH (% of THE) | Life expectancy at birth (years) | Area (km2) | Mean SRI (%) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | HC/C | Hospitals | HC/C | Hospitals | ||||||||
| Bangladeshd | 2014 | 1548d | 1381 | 167 | 1087 | 31 | 67 | 12 | 71.2 | 130 000 | 41 | 74 |
| Haitie | 2013 | 905e | 784 | 121 | 810 | 65 | 32 | 31 | 62.4 | 28 000 | 52 | 73 |
| Kenyaf | 2010 | 695 | 443 | 252 | 992 | 39 | 50 | 35 | 58.7 | 569 000 | 55 | 78 |
| Malawie | 2013 | 977e | 861 | 116 | 341 | 26 | 11 | 69 | 61.5 | 94 000 | 55 | 80 |
| Namibiae | 2009 | 411e | 366 | 45 | 4124 | 332 | 9 | 12 | 61.4 | 823 000 | 68 | 82 |
| Nepalf | 2015 | 963 | 716 | 247 | 744 | 40 | 48 | 13 | 70.0 | 143 000 | 44 | 76 |
| Rwandag | 2007 | 538e | 496 | 42 | 398 | 34 | 25 | 52 | 57.9 | 25 000 | 59 | 79 |
| Senegalf,h | 2012−2014 | 727d | 657 | 70 | 1051 | 47 | 39 | 27 | 66.4 | 193 000 | 60 | 69 |
| Ugandaf | 2007 | 491 | 372 | 119 | 410 | 48 | 42 | 22 | 53.7 | 201 000 | 41 | 76 |
| United Republic of Tanzaniaf | 2015 | 1188 | 932 | 256 | 865 | 52 | 23 | 36 | 65.5 | 886 000 | 48 | 82 |
| Full sample | 8443 | 7008 | 1435 | 52 | 77 | |||||||
ERFH: external resources for health; GDP: gross domestic product; HC/C: health centres/clinics; OOPE: out-of-pocket expenditure; SPA: service provision assessment; THE: total health expenditure; US$: United States dollars.
a For closest year available to year of service provision assessment.
b To the closest 1000 km2.
c The corresponding intraclass correlation coefficients were 0.29 for health centres/clinics and 0.09 for hospitals. The mean service-readiness-index values recorded for all facilities, health centres/clinics and hospitals were 54% (standard deviation, SD:17), 77% (SD:12) and 52% (SD:16), respectively.
d Data came from sample considered representative of the country’s health system, excluding small private facilities.
e Sample is a census of health facilities
f Data came from sample considered representative of the country’s health system.
g Data came from a census of public facilities and of private facilities with at least 5 staff plus a sample of small private facilities
h Sample collected over 2 waves representing the first 2 years of a continuous 5-year assessment
Data sources: World Bank Global Development indicators, World Health Organization Global Health Observatory and authors’ analysis of data from service provision assessments.
Characteristics and service readiness of health facilities in study sample, 10 countries, 2007–2015
| Characteristic | No. (%) | No. of facilities with relevant data available | ||
|---|---|---|---|---|
| All facilities ( | Health centres/clinics ( | Hospitals ( | ||
| Hospital as facility type | 636 (8) | 0 (0) | 636 (100) | 8443 |
| Private sector | 2676 (32) | 2335 (30) | 340 (53) | 8443 |
| Urbanb | 1238 (29) | 1017 (26) | 221 (73) | 5345 |
| Facility income includes donor supportc | 1714 (21) | 1483 (20) | 232 (37) | 8223 |
| Facility income includes user fees for services | 4972 (60) | 4440 (58) | 532 (84) | 8372 |
| Facility attained 100% service readiness index: | ||||
| For basic amenities | 339 (4) | 148 (2) | 191 (30) | 8443 |
| For basic basic equipment | 2269 (27) | 1986 (25) | 283 (44) | 8443 |
| For basic infection prevention | 1012 (12) | 836 (12) | 176 (28) | 8443 |
| For basic diagnostic capacity | 199 (2) | 111 (1) | 88 (14) | 8443 |
| For basic essential medications | 151 (2) | 51 (1) | 100 (16) | 8443 |
| For overall service readiness | 1 (0) | 0 (0) | 1 (0) | 8443 |
a The percentages shown are based on the sample-weighted numbers of facilities for which the relevant data were available and not, always, on the numbers surveyed.
b The identification of a facility as urban or rural only occurred in the service provision assessments for five of the study countries: Bangladesh, Haiti, Malawi, Senegal and the United Republic of Tanzania
c In the assessments in nine of the study countries, donor support was defined as support from secular or faith-based organizations or other unspecified donors. In the assessment in Nepal, however, it was defined as support from sources other than government ministries, user fees and training colleges.
Fig. 1Differences between the service readiness indexes of private and public health facilities, ten countries, 2007–2015
Fig. 2Differences between the service readiness indexes of rural and urban health facilities, five countries, 2012–2015
Association of health system and facility characteristics with the facility service readiness index, nine countries, 2007–2015
| Characteristic | Separate models adjusted for survey year only | Adjusted model | ||||
|---|---|---|---|---|---|---|
| Estimated difference in SRI (95% CI) | R2 | Estimated difference in SRI (95% CI) | ||||
| Hospital as facility type | 25.8 (19.4 to 32.2) | < 0.01 | 0.17 | 21.5 (16.9 to 26.2) | < 0.01 | |
| Charges user fees | 12.6 (5.6 to 19.7) | < 0.01 | 0.15 | 6.7 (−0.3 to 13.7) | 0.06 | |
| Receives donor funding | 9.5 (4.9 to 14.2) | < 0.01 | 0.07 | 3.2 (1.3 to 5.1) | < 0.01 | |
| Privately managed | 11.1 (2.9 to 19.3) | 0.01 | 0.11 | 5.2 (−1.4 to 11.8) | 0.11 | |
| THE per capitab | −0.1 (−1.8 to 1.7) | 0.94 | 0.01 | NI | N/A | |
| % of THE represented by external support for health systemb | 0.9 (0.3 to 1.5) | 0.01 | 0.11 | 0.7 (−0.3 to 1.7) | 0.13 | |
| % of THE represented by out-of-pocket expensesb | −0.7 (−1.2 to −0.1) | 0.04 | 0.05 | 0.3 (−0.6 to 1.2) | 0.46 | |
| Land area of countryb | −0.1 (−0.5 to 0.2) | 0.29 | 0.02 | NI | N/A | |
| Survey year | −0.5 (−2.6 to 1.7) | 0.64 | 0.01 | 0.1 (−1.2 to 1.4) | 0.87 | |
CI: confidence interval; N/A: not applicable; NI: not included; SRI: service readiness index; THE: total health expenditure.
a The models were based on data from service provision assessments in 7851 health facilities. All of the models were weighted using sampling weights scaled so that each study country contributed equally. The adjusted model, which contained covariates found to give P-values below 0.2 in the separate models, gave an R2 value of 0.34.
b The estimated difference represented a 10% increase in this characteristic.